BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,426,891 | -49.3% | 1,347,000 | -50.9% | 0.00% | 0.0% |
| Q3 2021 | $2,816,000 | +363.9% | 2,741,000 | +356.8% | 0.00% | – |
| Q1 2021 | $607,000 | -91.2% | 600,000 | -90.6% | 0.00% | -100.0% |
| Q4 2020 | $6,864,000 | +66.7% | 6,396,000 | +63.0% | 0.00% | 0.0% |
| Q3 2020 | $4,118,000 | -30.5% | 3,924,000 | -19.0% | 0.00% | -25.0% |
| Q2 2020 | $5,921,000 | +104.2% | 4,845,000 | +75.1% | 0.00% | +33.3% |
| Q1 2020 | $2,900,000 | -28.2% | 2,767,000 | -27.6% | 0.00% | 0.0% |
| Q4 2019 | $4,039,000 | +116.1% | 3,823,000 | +112.4% | 0.00% | +50.0% |
| Q2 2019 | $1,869,000 | -41.1% | 1,800,000 | -41.9% | 0.00% | -33.3% |
| Q1 2019 | $3,172,000 | -3.3% | 3,100,000 | -6.1% | 0.00% | 0.0% |
| Q4 2018 | $3,281,000 | -51.1% | 3,300,000 | -47.6% | 0.00% | -50.0% |
| Q3 2018 | $6,714,000 | +32.9% | 6,300,000 | +26.0% | 0.01% | +20.0% |
| Q2 2018 | $5,051,000 | -12.7% | 5,000,000 | -18.9% | 0.01% | 0.0% |
| Q1 2018 | $5,786,000 | +45.2% | 6,163,000 | +54.1% | 0.01% | +25.0% |
| Q4 2017 | $3,985,000 | +22.2% | 4,000,000 | +24.2% | 0.00% | +33.3% |
| Q3 2017 | $3,262,000 | – | 3,220,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 25,130,000 | $26,845,000 | 3.25% |
| ZAZOVE ASSOCIATES LLC | 33,935,000 | $35,929,000 | 3.11% |
| Cheyne Capital Management (UK) LLP | 3,000,000 | $3,179,000 | 1.89% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 73,250,000 | $77,604,000 | 1.60% |
| Sonora Investment Management, LLC | 7,390,000 | $7,792,000 | 1.08% |
| Lombard Odier Asset Management (Europe) Ltd | 11,613,000 | $12,391,000 | 0.86% |
| SSI INVESTMENT MANAGEMENT LLC | 6,083,000 | $6,421,000 | 0.50% |
| MACKAY SHIELDS LLC | 53,388,000 | $57,017,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 18,865,000 | $20,150,000 | 0.27% |
| LOOMIS SAYLES & CO L P | 907,254 | $120,544,000 | 0.24% |